Natco Pharma consolidated Q1FY23 PAT jumps to Rs. 320.4 Cr
News

Natco Pharma consolidated Q1FY23 PAT jumps to Rs. 320.4 Cr

The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022.

  • By IPP Bureau | August 10, 2022

Natco Pharma Limited has posted net profit of Rs. 320.4 crores for the period ended June 30, 2022 as against net loss of Rs. 50.5 crores for the period ended March 31, 2022. The company posted net profit of Rs.75 crores for the period ended June 30, 2021.

The company has reported total income of Rs. 918.9 crores during the period ended June 30, 2022 as compared to Rs. 610.6 crores during the period ended March 31, 2022. It reported total income of Rs.427.3 crores during the period ended June 30, 2021.

 

Upcoming E-conference

Other Related stories

Startup

Digitization